Viola sells JAZZ 149.74: Analysis of Relative Performance in the Pharmaceuticals Industry for Shares of Jazz Pharmaceuticals (JAZZ, VVUS, NKTR, DEPO, MDC ...
This is what we found: Jazz Pharmaceuticals (NASDAQ:JAZZ) ranks first with a loss of 3.50%; Vivus (NASDAQ:VVUS) ranks second with a loss of 3.21%; and Nektar Therapeutics (NASDAQ:NKTR) ranks third with a loss of 2.66%. Depomed (NASDAQ:DEPO) follows with a ... ...
61 people liked this
0 Comments:
Post a Comment
Subscribe to Post Comments [Atom]
<< Home